Functions of myeloid cells.

Slides:



Advertisements
Similar presentations
Clancy-Thompson et al., Supplemental Figure 1 A B C Supplemental Figure 1: Mice were given intravenous B16 injection on day 0. A) After bearing tumors.
Advertisements

IL-1β stimulates CXCL5 and CXCL8 gene expression and protein secretion in A549 cells in a time- and dose-dependent manner. IL-1β stimulates CXCL5 and CXCL8.
Pak2 regulates myeloid-derived suppressor cell development in mice
Frequencies of immune cell types show much stronger variations between tumor types in the tumor infiltrate compared with the spleen and tumor-draining.
Effects of SC144 on in vivo ovarian tumor.
H31m1-PDL1 cells form progressively growing tumors in WT mice.
IL-6 is dispensable for the suppressive activity of MDSC on primary CD4+ T-cell activation. IL-6 is dispensable for the suppressive activity of MDSC on.
A, RT-qPCR of ROR1 mRNA expression in B-CLL cells and a panel of human and rhesus macaque tissues. A, RT-qPCR of ROR1 mRNA expression in B-CLL cells and.
Mean and difference Raman spectra of T cells isolated from spleen of sham mice and endotoxemic mice for time points 1, 4, 10, and 30 d. Mean and difference.
Gr-1+ MDSC in tumor-bearing mice produce IL-6.
Increased chemokine content and leukocyte infiltrate in D6-negative tumors. Increased chemokine content and leukocyte infiltrate in D6-negative tumors.
Caspase-1 from myeloid cells induces tumor proliferation via MyD88 oncogenic signaling. Caspase-1 from myeloid cells induces tumor proliferation via MyD88.
Splenic CD169+ macrophages express a unique gene profile.
Volume 38, Issue 3, Pages (March 2013)
Epithelial loss of TβRII results in increased Th17 cell development.
2aG4 directly induces monocytic MDSCs to differentiate into dendritic cells and macrophages by binding to phosphatidylserine on their cell surface. 2aG4.
Fig. 4 Surgery initiates a systemic inflammatory response that triggers the outgrowth of distant immunogenic tumors and can be inhibited by perioperative.
The human GPR109A promoter is methylated and GPR109A expression is silenced in human colon carcinoma cells. The human GPR109A promoter is methylated and.
Karima R.R. Siddiqui, Sophie Laffont, Fiona Powrie  Immunity 
PCA-LDA of Raman spectra of T cells isolated from spleen of sham mice and endotoxemic mice for time points 1, 4, 10 and 30 d. PCA-LDA of Raman spectra.
Volume 12, Issue 2, Pages (July 2015)
Highly related T9 and T3 sarcoma cells show distinct tumor growth patterns but similar PD-L1 expression kinetics in vivo. Highly related T9 and T3 sarcoma.
PD1 targeting alters the recruitment of immune cells to MC38 CRC tumors. PD1 targeting alters the recruitment of immune cells to MC38 CRC tumors. MC38.
Exosome-mediated inhibition of T cells is reversible.
CT-26 colon cancer induces the recruitment of protumor mast cells and the accumulation of MDSCs. CT-26 colon carcinoma cells (2 × 105) were injected s.c.
Interacting MDSCs and mast cells (MC) in human colon carcinoma and in the colon of AOM/DSS-induced tumor-bearing mice. Interacting MDSCs and mast cells.
Mice immunized twice with RRBC showed superior protection to tumor challenge with αGal-positive MC38 colon carcinoma cells compared with mock-immunized.
Autophagy restrains pancreatic inflammation and expression of pTBK1, CCL5, and PD-L1 in vivo. Autophagy restrains pancreatic inflammation and expression.
Combined BRAFi and anti-CTLA4 administration leads to prolonged antitumor immunity in a patient with metastatic melanoma. Combined BRAFi and anti-CTLA4.
Reduced tumor growth in CCR5-deficient mice is associated with perturbed killing ability of Treg cells. Reduced tumor growth in CCR5-deficient mice is.
Figure 3. Enhancement of cytokine production by CD8+ T cells at TT
Conversion of CD11bhighCD27high NK cells into MDSCs leads to CD11bhighCD27high and CD11bhighCD27low NK cell reduction. Conversion of CD11bhighCD27high.
CD49b+ cells from tumor-bearing mice are more prone to conversion into MDSCs compared with naive CD49b+ cells. CD49b+ cells from tumor-bearing mice are.
CD11bhighCD27high conventional NK cells are converted into MDSCs
Tumor metastasis is mediated by neutrophils.
Antigen-specific CD8+ T cells express higher levels of PD-1 in animals that received the optimized SSX2 vaccine. Antigen-specific CD8+ T cells express.
Inflammation Mediated by JNK in Myeloid Cells Promotes the Development of Hepatitis and Hepatocellular Carcinoma  Myoung Sook Han, Tamera Barrett, Michael.
EMT gene expression patterns of M-Wnt and E-Wnt cells in vitro and in vivo. EMT gene expression patterns of M-Wnt and E-Wnt cells in vitro and in vivo.
PD-L1 expressed on edited T3 sarcoma cells prevents their immune elimination. PD-L1 expressed on edited T3 sarcoma cells prevents their immune elimination.
SAF-1 expression in clinical breast cancer tissues.
5FU-induced specific activation of CD8+ T cells.
CDN–treated MOC1 tumors demonstrate enhanced activation of innate and antigen-specific adaptive immunity. CDN–treated MOC1 tumors demonstrate enhanced.
Microarray analysis of global gene expression profiles of PC-3 and derivative cell lines. Microarray analysis of global gene expression profiles of PC-3.
Expression of lnc-C/EBPβ in inflammation and in MDSCs induced by tumor-associated factors. Expression of lnc-C/EBPβ in inflammation and in MDSCs induced.
HMQ1611 inhibited breast tumor growth in mice.
DAC treatment alters immune cell composition and enhances cytokine production in the peritoneal lavage. DAC treatment alters immune cell composition and.
Deletion of Tgfbr2 in myeloid cells elevated IFN-γ production in CD8+ T cells, and systemic IFN-γ neutralization diminished metastasis inhibition in Tgfbr2MyeKO.
Reconstitution of the wild-type CD11b+Ly6G+ myeloid cell subset in Tgfbr2MyeKO mice reversed the diminished metastasis phenotype. Reconstitution of the.
Effect of inhibiting HO-1 on adaptive immune- and cytokine-dependent regulation of tumor growth. Effect of inhibiting HO-1 on adaptive immune- and cytokine-dependent.
MDSC-derived IL-6 enhances tumor progression through the inhibition of tumor-specific TH1 development and of their helper activity for CD8+ T cells. MDSC-derived.
Role of NO and IFNγ in mast cell–dependent MDSC-suppressive activities
TAMs directly contribute to tumor hypoxia.
Anti-CD40 activates TAMs and recruits inflammatory monocytes.
Histology (H&E; original magnification, ×100 for B-2P/C-12P/C-64P and ×40 for C-10P; top) of small-sized lung adenocarcinomas and immunohistochemical staining.
Combination of R848 and anti-CD200R affects activation of tumor-infiltrating myeloid cells. Combination of R848 and anti-CD200R affects activation of tumor-infiltrating.
Immune checkpoint molecule expression in primary and secondary tumors following radiotherapy. Immune checkpoint molecule expression in primary and secondary.
Validation of NAA's cancer specificity in lung cancer.
LDL cholesterol inhibits Vγ9Vδ2 T-cell activation and cytokine production. LDL cholesterol inhibits Vγ9Vδ2 T-cell activation and cytokine production. Preexpanded.
Tumor-suppressor Lkb1 inactivation promotes neutrophil accumulation via proinflammatory cytokines and chemokines. Tumor-suppressor Lkb1 inactivation promotes.
IL35 regulation of tumor growth is accompanied by suppression of CD4+ effector T-cell activity and expansion of Tregs. IL35 regulation of tumor growth.
The effect of βAR signaling on the generation of a cytotoxic CD8+ T-cell response in vivo. The effect of βAR signaling on the generation of a cytotoxic.
Fig. 7 Differences in the tumor microenvironment between transplant and transgenic BRAFV600E-driven melanoma models may underlie refractoriness of iBIP2.
Gene expression heatmap of non–T-cell-inflamed, intermediate, and T-cell–inflamed testicular germ cell tumors from TCGA. Genes are on the row, and samples.
In vivo inhibition of IL-17 abrogates tumor-promoting effect of myeloid cells. In vivo inhibition of IL-17 abrogates tumor-promoting effect of myeloid.
Lnc-C/EBPβ negatively regulates immune-suppressive function of MDSCs in vivo. Lnc-C/EBPβ negatively regulates immune-suppressive function of MDSCs in vivo.
Depletion of CD8+, CD4+, and Ly6G+ cells in subcutaneous TUBO tumor-bearing BALB/c mice treated with KM100 + MTX. Depletions were conducted by intraperitoneal.
CD38 regulates tumor growth and metastasis by adenosine-mediated CD8+ T-cell suppression. CD38 regulates tumor growth and metastasis by adenosine-mediated.
EC-derived SP cells are targeted by CD30.CAR T cells.
Varying the MHC-I affinity, TCR affinity or antigen dose alters the phenotype of CD8 T cells ex vivo. Varying the MHC-I affinity, TCR affinity or antigen.
RIL21 and checkpoint blockade restore IFNγ production in Tim-3+PD-1+ intratumoral NK cells from cancer patients. rIL21 and checkpoint blockade restore.
Presentation transcript:

Functions of myeloid cells. Functions of myeloid cells. A, Cell sorting strategy. B, T-cell (CD3+) gene expression profile. Cells were sorted as shown in A. Top row, gene expression for Th2 cytokines presented as ΔΔCt normalized to Gapdh; bottom row, gene expression for Th1 cytokines presented as ΔΔCt normalized to Gapdh. Data correspond to the mean ± SEM of 3 individual mice from two experiments. *, P < 0.01. C, Gene expression analysis of protumorigenic cytokines previously identified as cytokine mediators of MDSC immune suppression. Top, gene expression measured by qPCR on sorted Ly6G; middle, gene expression analysis of Gr1+ cells, from the spleen of 4T1 tumor-bearing mice, treated with conditioned media from Kras/p48 (open bars) or from Kras/p48TGFβRII-KO (closed bars) carcinoma cells; bottom row, gene expression analysis of Gr1+ cells, from the spleen of 4T1 tumor-bearing mice, treated with G-CSF, 20 ng/mL for 6 hours. Data correspond to the mean ± SEM of 3 individual mice from two experiments. **, P < 0.05; *, P < 0.01. D, T cells (CD3+) were isolated by negative selection from spleen of naïve BALB/c mice, mixed with CD11b cells isolated from pancreatic tissue by using CD11b magnetic microbeads (Miltenyi Biotec), anti–G-CSF was used in concentration 40 ng/mL. Data correspond to the mean ± SEM of three individual mice. *, P < 0.05. Michael W. Pickup et al. Cancer Immunol Res 2017;5:718-729 ©2017 by American Association for Cancer Research